http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-110405-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecb7d7f3a37cdebeffcaafcbab7bcb1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
filingDate 2017-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-110405-A1
titleOfInvention COMPOUNDS
abstract Claim 1: Compound of formula (1), wherein R¹ is each independently selected from the group consisting of i) amino, ii) C₁₋₆ alkyl, iii) C₁₋₆ alkoxy, iv) cyano, v) halogen , vi) halogen Cógeno alkyl, vii) halogen C₁₋₆ alkoxy, and viii) hydroxy; R² is each independently selected from the group consisting of i) amino, ii) aryl substituted with (R³) iii, iii) C₁₋₆ alkyl, iv) C₁₋₆ alkoxy, v) C₂₋₆ alkynyl substituted with (R⁵ ) ₚ, vi) cyano, vii) halogen, viii) halogen C₁₋₆ alkyl, ix) halogen Cco haloxy, x) heteroaryl substituted with (R⁴) ₗ, xi) heterocyclyl substituted with (R⁷) ʳ and xii) hydroxy; R³ is each independently selected from the group consisting of i) amino, ii) C₁₋₆ alkyl, iii) C₁₋₆ alkoxy, iv) cyano, v) halogen, vi) C₁₋₆ halogenalkyl, vii) Cco halogenalkoxy ₆, and viii) hydroxy; R⁴ is each independently selected from the group consisting of i) amino, ii) C₁₋₆ alkyl, iii) C₁₋₆ alkoxy, iv) cyano, v) halogen, vi) C₁₋₆ halogenalkyl, vii) C₁₋ halogenalkoxy ₆, viii) heterocyclyl substituted with (R⁸) ₛ, and ix) hydroxy; R⁵ is independently selected from the group consisting of i) heteroaryl substituted with (R⁶) q, and ii) C₁₋₆ alkyl; R⁶ is independently selected from the group consisting of i) amino, and ii) C₁₋₆ alkyl; R⁷ is independently selected from the group consisting of i) amino, and ii) C₁₋₆ alkyl; R⁸ is independently selected from the group consisting of i) amino, and ii) C₁₋₆ alkyl; Het is heteroaryl; k is 0, 1, 2 or 3; l is 0, 1 or 2; n is 0, 1, 2 or 3; m is 0, 1 or 2; p is 0, 1 or 2; q is 0, 1 or 2; r is 0, 1 or 2; s is 0, 1 or 2; or a pharmaceutically acceptable salt thereof.
priorityDate 2016-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 38.